GlucoTrack unit Lokahi Therapeutics expands ai2 Futures Lab collaboration with University of Georgia
GCTK•First-year results from the lab
In its first year, the lab engaged 64 students, identifying more than 45 potential acquisition assets; several moved into active discussions.
Program aims to source overlooked therapeutic assets
The program aims to expand sourcing of therapeutic acquisition candidates viewed as overlooked or deprioritized, supporting pipeline build-out.
Lokahi Therapeutics renews University of Georgia participation
GlucoTrack’s Lōkahi Therapeutics renewed the University of Georgia’s participation in its ai² Futures Lab asset-origination program.
